ReviewClinical liver disease2018

CON ("The window is closed"): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed.

Ariel W Aday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.